关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 2 3 0 9 2 6 7 位浏览者
您当前的位置:首页 >> 正文

LC-MS/MS法同时测定参芍胶囊中人参皂苷和芍药苷的含量

Simultaneous determination of ginsenosides and paeoniflorin in Shenshao capsules by LC-MS/MS

作者(英文):
分类号:R917
出版年·卷·期(页码):2018,38 (1):186-190
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立高效液相色谱-串联质谱(LC-MS/MS)法同时测定参芍胶囊中人参皂苷Rb2、Rd、Re、Rg1和芍药苷的含量。方法:采用Hypersil Gold C18色谱柱(2.1 mm×100 mm,3 μm),以乙腈-0.1%甲酸水溶液为流动相,梯度洗脱(0~10 min,15%乙腈→40%乙腈;10~13 min,40%乙腈→70%乙腈),流速0.3 mL·min-1,柱温40℃;采用电喷雾离子源(ESI),多反应监测(MRM)模式,负离子检测。结果:人参皂苷Rb2、Rd、Re、Rg1和芍药苷的线性范围分别为0.01~12.66 μg·mL-1r=0.999 7)、0.01~10.34 μg·mL-1r=0.999 6)、0.02~17.44 μg·mL-1r=0.999 1)、0.02~17.29 μg·mL-1r=0.999 1)和0.01~11.76 μg·mL-1r=0.999 9),平均加样回收率(n=6)均在96.8%~100.1%范围内。3批样品中人参皂苷Rb2、Rd、Re、Rg1和芍药苷的含量测定结果分别为3.903~3.990、6.555~6.628、10.69~11.42、7.024~8.381和84.65~86.87 mg·g-1结论:所建立的方法可用于参芍胶囊的质量控制。

-----英文摘要:---------------------------------------------------------------------------------------

Objective:To establish an LC-MS/MS method for simultaneous determination of ginsenoside Rb2,ginsenoside Rd,ginsenoside Re,ginsenoside Rg1 and paeoniflorin in Shenshao capsules by LC-MS/MS. Methods:The chromatographic separation was performed on a Hypersil Gold C18 column(2.1 mm×100 mm, 3 μm)with a mobile phase consisting of acetonitrile-0.1% formic acid at the flow rate of 0.3 mL·min-1(0-10 min,15% acetonitrile→40% acetonitrile;10-13 min,40% acetonitrile→70% acetonitrile).The column temperature was 40℃.Negative electrospray ionization source(ESI)was used combined with multiple reaction monitoring(MRM).Results:Good linearity was obtained in the range of 0.01-12.66 μg·mL-1(r=0.999 7)for ginsenoside Rb2,0.01-10.34 μg·mL-1(r=0.999 6)for ginsenoside Rd,0.02-17.44 μg·mL-1(r=0.999 1)for ginsenoside Re,0.02-17.29 μg·mL-1(r=0.999 1)for ginsenoside Rg1 and 0.01-11.76 μg·mL-1(r=0.999 9)for paeoniflorin, respectively.The average recoveries of five components were 96.8%-100.1%.The contents of ginsenoside Rb2,ginsenoside Rd,ginsenoside Re,ginsenoside Rg1 and paeoniflorin in 3 batches of samples were 3.903-3.990 mg·g-1,6.555-6.628 mg·g-1,10.69-11.42 mg·g-1,7.024-8.381 mg·g-1 and 84.65-86.87 mg·g-1,respectively.Conclusion:The established method can be used for the quality control of Shenshao capsules.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 769位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn